financetom
Business
financetom
/
Business
/
Acushnet Holdings Insider Sold Shares Worth $491,400, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Acushnet Holdings Insider Sold Shares Worth $491,400, According to a Recent SEC Filing
Jun 5, 2024 1:42 PM

04:27 PM EDT, 06/05/2024 (MT Newswires) -- Christopher Aaron Lindner, President, FootJoy, on June 03, 2024, sold 7,500 shares in Acushnet Holdings ( GOLF ) for $491,400. Following the Form 4 filing with the SEC, Lindner has control over a total of 93,710 shares of the company, with 93,710 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672013/000112760224017922/xslF345X03/form4.xml

Price: 66.02, Change: -0.02, Percent Change: -0.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NHTSA opens probe into 74,702 Nissan Rogue vehicles
NHTSA opens probe into 74,702 Nissan Rogue vehicles
Jun 3, 2024
(Reuters) - The National Highway Traffic Safety Administration said on Monday it has opened a probe into 74,702 Nissan Rogue Select vehicles due to the inadvertent deployment of side curtain airbags. ...
Sector Update: Consumer Stocks Mixed Premarket Monday
Sector Update: Consumer Stocks Mixed Premarket Monday
Jun 3, 2024
09:16 AM EDT, 06/03/2024 (MT Newswires) -- Consumer stocks were mixed premarket Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.2% lower and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) slightly advancing recently. GameStop ( GME ) surged past 70% after trader Keith Gill posted on his Reddit account Roaring Kitty a screenshot...
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival
Jun 3, 2024
09:16 AM EDT, 06/03/2024 (MT Newswires) -- Moderna ( MRNA ) and Merck ( MRK ) said Monday that results from the phase 2b clinical trial assessing mRNA-4157 (V940) plus Merck's ( MRK ) Keytruda in patients with resected high-risk melanoma after complete resection showed sustained improvement in recurrence-free survival, the study's primary endpoint. The companies said that with a...
Science Applications International Optimistic About Hitting Annual Outlook Despite Q1 Revenue Dip, Shares Slide
Science Applications International Optimistic About Hitting Annual Outlook Despite Q1 Revenue Dip, Shares Slide
Jun 3, 2024
Science Applications International Corp ( SAIC ) reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate. The sale of the logistics and supply chain management business and contract completions mainly led to the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved